A Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation

Clinical trial NCT01478529 · COMPLETED

Trial details

NCT number: NCT01478529
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics of Mirabegron Bioavailability Healthy Subjects

Start date: 2006-02-01
Primary completion: 2006-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.